Eli Lilly vs Merck & Co
Eli Lilly (LLY), health care, and Merck & Co (MRK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Eli Lilly is worth $1.26T on the stock market and Merck & Co $354.4B: Eli Lilly is valued at 3.6 times as much. Eli Lilly trades at 45.9 times earnings and Merck & Co at 145. Over the past year Eli Lilly's share price has moved +39.0% and Merck & Co's +49.8%.
Key facts
- Eli Lilly market value
- $1.26T
- Merck & Co market value
- $354.4B
- Eli Lilly P/E
- 45.9
- Merck & Co P/E
- 145
- Eli Lilly revenue
- $65.2BFY to 2025-12-31
- Merck & Co revenue
- $65BFY to 2025-12-31
- Superinvestors holding both
- 12
Market values as of .
| Measure | Eli Lilly | Merck & Co |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $1.26Thigher | $354.4Blower |
| Revenue | $65.2Bhigher | $65Blower |
| Earnings | $20.6Bhigher | $18.3Blower |
| Employees | 50,000lower | 73,000higher |
| Total assets | $112.5Blower | $136.9Bhigher |
| Valuation | ||
| P/E | 45.9lower | 145higher |
| P/S | 19.3higher | 5.5lower |
| P/B | 31.3higher | 7.9lower |
| Dividend yield | 0.47%lower | 2.33%higher |
| Profitability | ||
| Operating margin | — | — |
| Balance sheet | ||
| Net assets | $26.5Blower | $52.6Bhigher |
| Total liabilities | $85.9Bhigher | $84.2Blower |
| Total debt | $42.5Blower | $49.3Bhigher |
| Cash on hand | $7.3Blower | $14.6Bhigher |
| Price change | ||
| Today | -1.22%lower | -0.48%higher |
| 1 year | +39.0%lower | +49.8%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (12)
- Mairs & Power team3.4% / 0.1%
- Jeremy Grantham (co-founder)1.9% / 1.6%
- Ken Fisher1.8% / 1.7%
- Rajiv Jain1.6% / <0.1%
- Ken Griffin0.7% / 0.1%
- Temasek0.5% / 0.3%
- Brandon Haley0.5% / 0.2%
- Cliff Asness0.4% / 0.4%
- David Shaw (founder)0.4% / 0.2%
- Murray Stahl0.1% / 0.1%
- Dodge & Cox team<0.1% / <0.1%
- Bill Nygren<0.1% / 2.1%
Eli Lilly only (16)
- Primecap team6.5%
- Polen Capital team4.6%
- Jensen team4.0%
- Larry Robbins1.4%
- Cathie Wood0.7%
- Jeffrey Altman0.6%
- Ray Dalio (founder)0.4%
- George Soros0.4%
- Stanley Druckenmiller0.3%
- Mario Gabelli0.3%
- John Overdeck and David Siegel (founders)0.3%
- Frank Sands0.2%
- Ron Baron0.2%
- Paul Tudor Jones0.2%
- Israel Englander0.1%
- Rob Citrone0.1%
Merck & Co only (11)
- Bill Smead7.1%
- Thomas Kahn4.9%
- Howard Gleicher2.0%
- Charles Brandes (founder)1.5%
- Josef Lakonishok1.4%
- Prem Watsa0.9%
- Christopher Bloomstran0.6%
- Sarah Ketterer0.6%
- Mark Boyar0.5%
- Joel Greenblatt0.2%
- Thomas Russo<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Eli Lilly / Merck & Co). Who owns LLY · Who owns MRK
More on Eli Lilly
Further comparisons
Eli Lilly against its closest peers
Merck & Co against its closest peers
Learn
Questions and answers
Which is bigger, Eli Lilly or Merck & Co?
By market value, Eli Lilly is the larger: $1.26T against $354.4B for Merck & Co. By revenue in its latest fiscal year, Eli Lilly is the larger: $65.2B against $65B for Merck & Co.
Which has the higher P/E ratio?
Merck & Co: 145, against 45.9 for Eli Lilly. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
Merck & Co: 2.33%, against 0.47% for Eli Lilly. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Merck & Co: $49.3B, against $42.5B for Eli Lilly. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Eli Lilly and Merck & Co?
In their latest 13F filings, Mairs & Power team, Jeremy Grantham (co-founder), Ken Fisher, Rajiv Jain, Ken Griffin, Temasek, Brandon Haley, Cliff Asness, David Shaw (founder), Murray Stahl, Dodge & Cox team and Bill Nygren hold both.
Cite this page
Funkfolio, “Eli Lilly vs Merck & Co”, data as of 17 November 2026. https://funkfolio.com/compare/lly-vs-mrk
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.